Literature DB >> 10459478

High rate of non-albicans candidemia in Brazilian tertiary care hospitals.

A L Colombo1, M Nucci, R Salomão, M L Branchini, R Richtmann, A Derossi, S B Wey.   

Abstract

In order to evaluate the epidemiology of candidemia in Brazil, we performed a prospective multicenter study conducted in six general hospitals from São Paulo and Rio de Janeiro, We enrolled a total of 145 candidemic patients (85 males) with a median age of 32 years. Non-albicans species accounted for 63% of all episodes and the species most frequently causing candidemia were C. albicans (37%), C. parapsilosis (25%), C. tropicalis (24%), C. rugosa (5%), and C. glabrata (4%). Systemic azoles were used before the onset of candidemia in only six patients. There were no differences in the coexisting exposures or underlying diseases associated with the species most frequently causing candidemia. The overall crude mortality rate was 50%. Nosocomial candidemias in our tertiary hospitals are caused predominantly by non-albicans species, which are rarely fluconazole resistant. This predominance of non-albicans species could not be related to the previous use of azoles.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10459478     DOI: 10.1016/s0732-8893(99)00042-5

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  43 in total

1.  Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

2.  Electrophoretic variants of intracellular catalase of different Candida species.

Authors:  N R S Miyasak; C S Unterkircher; P O Carvalho; M T Shimizu
Journal:  Mycopathologia       Date:  2004-08       Impact factor: 2.574

3.  Diagnosis of candidemia by polymerase chain reaction and blood culture: prospective study in a high-risk population and identification of variables associated with development of candidemia.

Authors:  M S Moreira-Oliveira; Y Mikami; M Miyaji; T Imai; A Z Schreiber; M L Moretti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

4.  Inhibition of fungal beta-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies.

Authors:  Dakshnamurthy Selvakumar; Masahiko Miyamoto; Yasuhiro Furuichi; Tadazumi Komiyama
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

5.  Evidence for a pseudo-outbreak of Candida guilliermondii fungemia in a university hospital in Brazil.

Authors:  Eduardo Alexandrino Servolo Medeiros; Timothy J Lott; Arnaldo Lopes Colombo; Patrício Godoy; Ana Paula Coutinho; Monica Santos Braga; Marcio Nucci; Mary E Brandt
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

Review 6.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

7.  New approach for diagnosis of candidemia based on detection of a 65-kilodalton antigen.

Authors:  Rodrigo Berzaghi; Arnaldo Lopes Colombo; Antonia Maria de Oliveira Machado; Zoilo Pires de Camargo
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

8.  Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis.

Authors:  Shawn R Lockhart; Shawn A Messer; Michael A Pfaller; Daniel J Diekema
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

9.  Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen.

Authors:  Emmanuel Roilides; Evangelia Farmaki; Joanna Evdoridou; Andrea Francesconi; Miki Kasai; Joanna Filioti; Maria Tsivitanidou; Danai Sofianou; George Kremenopoulos; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

10.  Studies on the antifungal properties of N-thiolated beta-lactams.

Authors:  Marci O'Driscoll; Kerriann Greenhalgh; Ashley Young; Edward Turos; Sonja Dickey; Daniel V Lim
Journal:  Bioorg Med Chem       Date:  2008-06-25       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.